Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Transcranial Magnetic Stimulation to Improve Speech in Aphasia
Transcranial Magnetic Stimulation to Improve Speech
Status: Enrolling
Updated:  3/29/2011
Berenson-Allen Center for Noninvasive Brain Stimulation, 330 Brookline Ave, Kirstein Bldg., Dept. of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School
mi
from
Boston, MA
Transcranial Magnetic Stimulation to Improve Speech in Aphasia
Transcranial Magnetic Stimulation to Improve Speech
Status: Enrolling
Updated: 3/29/2011
Berenson-Allen Center for Noninvasive Brain Stimulation, 330 Brookline Ave, Kirstein Bldg., Dept. of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School
mi
from
Boston, MA
Click here to add this to my saved trials
Transcranial Magnetic Stimulation to Improve Speech in Aphasia
Transcranial Magnetic Stimulation to Improve Speech
Status: Enrolling
Updated:  3/29/2011
Department of Neurology, Hospital of the University of Pennsylvania, 3 W. Gates Bldg.
mi
from
Philadelphia, PA
Transcranial Magnetic Stimulation to Improve Speech in Aphasia
Transcranial Magnetic Stimulation to Improve Speech
Status: Enrolling
Updated: 3/29/2011
Department of Neurology, Hospital of the University of Pennsylvania, 3 W. Gates Bldg.
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Neurological Surgery & Affiliated Services De-Identified Clinical Outcomes Database
Neurological Surgery & Affiliated Services De-Identified Clinical Outcomes Database
Status: Enrolling
Updated:  4/1/2011
University of California, Irvine Medical Center
mi
from
Orange, CA
Neurological Surgery & Affiliated Services De-Identified Clinical Outcomes Database
Neurological Surgery & Affiliated Services De-Identified Clinical Outcomes Database
Status: Enrolling
Updated: 4/1/2011
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Telephone Support for Dementia Caregivers
Psychosocial Telephone Intervention for Dementia Caregivers
Status: Enrolling
Updated:  4/5/2011
Rhode Island Hospital
mi
from
Providence, RI
Telephone Support for Dementia Caregivers
Psychosocial Telephone Intervention for Dementia Caregivers
Status: Enrolling
Updated: 4/5/2011
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Carl T. Hayden Medical Research Foundation
mi
from
Phoenix, AZ
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Carl T. Hayden Medical Research Foundation
mi
from
Phoenix, AZ
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
University of California at San Francisco
mi
from
San Francisco, CA
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
University of Miami
mi
from
Miami, FL
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Northwestern University
mi
from
Chicago, IL
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Tufts Medical Center
mi
from
Boston, MA
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Wayne State University
mi
from
Detroit, MI
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Michigan State University
mi
from
East Lansing, MI
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Michigan State University
mi
from
East Lansing, MI
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Gotham Cardiovascular Research PC
mi
from
New York, NY
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Gotham Cardiovascular Research PC
mi
from
New York, NY
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
New York University School of Medicine
mi
from
New York, NY
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Baylor College of Medicine
mi
from
Houston, TX
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Western Institute for Biomedical Research
mi
from
Salt Lake City, UT
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Western Institute for Biomedical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Univ of Washington
mi
from
Seattle, WA
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
West Virginia University
mi
from
Morgantown, WV
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
West Virginia University
mi
from
Morgantown, WV
Click here to add this to my saved trials
Using Optical Coherence Tomography (OCT) to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Patients With Relapsing Multiple Sclerosis
Optical Coherence Tomography (OCT) in a Multicenter, Randomized,Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  4/15/2011
Johns Hopkins University
mi
from
Baltimore, MD
Using Optical Coherence Tomography (OCT) to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Patients With Relapsing Multiple Sclerosis
Optical Coherence Tomography (OCT) in a Multicenter, Randomized,Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Subjects With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 4/15/2011
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
A Prospective Single Institution Study of Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
Status: Enrolling
Updated:  4/21/2011
Allegheny General Neurology Department/Neuro-Oncology
mi
from
Pittsburgh, PA
Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
A Prospective Single Institution Study of Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
Status: Enrolling
Updated: 4/21/2011
Allegheny General Neurology Department/Neuro-Oncology
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Status: Enrolling
Updated:  5/11/2011
Advent Research
mi
from
Pinellas Park, FL
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Status: Enrolling
Updated: 5/11/2011
Advent Research
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Status: Enrolling
Updated:  5/11/2011
Medical College of Georgia Movements Disorders Program
mi
from
Augusta, GA
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Status: Enrolling
Updated: 5/11/2011
Medical College of Georgia Movements Disorders Program
mi
from
Augusta, GA
Click here to add this to my saved trials
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Status: Enrolling
Updated:  5/11/2011
Northwestern University PD and Movement Disorders Center
mi
from
Chicago, IL
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Status: Enrolling
Updated: 5/11/2011
Northwestern University PD and Movement Disorders Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Status: Enrolling
Updated:  5/11/2011
Atlantic Neuroscience Institute Overlook Hospital
mi
from
Summit, NJ
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Status: Enrolling
Updated: 5/11/2011
Atlantic Neuroscience Institute Overlook Hospital
mi
from
Summit, NJ
Click here to add this to my saved trials
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Status: Enrolling
Updated:  5/11/2011
SUNY- Buffalo Jacobs Neurological Institute
mi
from
Buffalo, NY
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Status: Enrolling
Updated: 5/11/2011
SUNY- Buffalo Jacobs Neurological Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Status: Enrolling
Updated:  5/11/2011
Cleveland Clinic Sleep Disorders Center
mi
from
Cleveland, OH
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Status: Enrolling
Updated: 5/11/2011
Cleveland Clinic Sleep Disorders Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Status: Enrolling
Updated:  5/11/2011
University of Pennsylvania Sleep Center
mi
from
Philadelphia, PA
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Status: Enrolling
Updated: 5/11/2011
University of Pennsylvania Sleep Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Status: Enrolling
Updated:  5/11/2011
Charlottesville Medical Research
mi
from
, VA
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Status: Enrolling
Updated: 5/11/2011
Charlottesville Medical Research
mi
from
, VA
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  5/11/2011
Phoenix Neurological Associates
mi
from
Phoenix, AZ
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 5/11/2011
Phoenix Neurological Associates
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  5/11/2011
University Neurology Associates
mi
from
Fresno, CA
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 5/11/2011
University Neurology Associates
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  5/11/2011
California Pacific Medical Center
mi
from
San Francisco, CA
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 5/11/2011
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  5/11/2011
Mayo Clinic Florida
mi
from
Jacksonville, FL
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 5/11/2011
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  5/11/2011
University of Kentucky
mi
from
Lexington, KY
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 5/11/2011
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  5/11/2011
Johns Hopkins Hospital
mi
from
Baltimore, MD
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 5/11/2011
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  5/11/2011
Massachusetts General Hospital
mi
from
Boston, MA
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 5/11/2011
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  5/11/2011
Washington University
mi
from
St. Louis, MO
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 5/11/2011
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  5/11/2011
SUNY Upstate Medical Center
mi
from
Syracuse, NY
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 5/11/2011
SUNY Upstate Medical Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  5/11/2011
Duke University
mi
from
Durham, NC
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 5/11/2011
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  5/11/2011
Providence ALS Center
mi
from
Portland, OR
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 5/11/2011
Providence ALS Center
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  5/11/2011
Drexel University College of Medicine, Dept of Neurology
mi
from
Philadelphia, PA
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 5/11/2011
Drexel University College of Medicine, Dept of Neurology
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  5/11/2011
Penn State
mi
from
University Park, PA
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 5/11/2011
Penn State
mi
from
University Park, PA
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  5/11/2011
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 5/11/2011
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  5/11/2011
University of Vermont
mi
from
Burlington, VT
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 5/11/2011
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Evaluation of a Tongue Operated Assistive Technology for Individuals With Severe Paralysis
Development and Translational Assessment of a Tongue-Based Assistive Neuro-Technology for Individuals With Severe Neurological Disorders
Status: Enrolling
Updated:  5/13/2011
Georgia Institute of Technology
mi
from
Atlanta, GA
Evaluation of a Tongue Operated Assistive Technology for Individuals With Severe Paralysis
Development and Translational Assessment of a Tongue-Based Assistive Neuro-Technology for Individuals With Severe Neurological Disorders
Status: Enrolling
Updated: 5/13/2011
Georgia Institute of Technology
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluation of a Tongue Operated Assistive Technology for Individuals With Severe Paralysis
Development and Translational Assessment of a Tongue-Based Assistive Neuro-Technology for Individuals With Severe Neurological Disorders
Status: Enrolling
Updated:  5/13/2011
Shepherd Center
mi
from
Atlanta, GA
Evaluation of a Tongue Operated Assistive Technology for Individuals With Severe Paralysis
Development and Translational Assessment of a Tongue-Based Assistive Neuro-Technology for Individuals With Severe Neurological Disorders
Status: Enrolling
Updated: 5/13/2011
Shepherd Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluation of a Tongue Operated Assistive Technology for Individuals With Severe Paralysis
Development and Translational Assessment of a Tongue-Based Assistive Neuro-Technology for Individuals With Severe Neurological Disorders
Status: Enrolling
Updated:  5/13/2011
Northwestern University
mi
from
Chicago, IL
Evaluation of a Tongue Operated Assistive Technology for Individuals With Severe Paralysis
Development and Translational Assessment of a Tongue-Based Assistive Neuro-Technology for Individuals With Severe Neurological Disorders
Status: Enrolling
Updated: 5/13/2011
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of a Tongue Operated Assistive Technology for Individuals With Severe Paralysis
Development and Translational Assessment of a Tongue-Based Assistive Neuro-Technology for Individuals With Severe Neurological Disorders
Status: Enrolling
Updated:  5/13/2011
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Evaluation of a Tongue Operated Assistive Technology for Individuals With Severe Paralysis
Development and Translational Assessment of a Tongue-Based Assistive Neuro-Technology for Individuals With Severe Neurological Disorders
Status: Enrolling
Updated: 5/13/2011
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Normothermia Protocol for Traumatic Brain Injury Patients
Normothermia Protocol for Traumatic Brain Injury Patients: An Outcome Study
Status: Enrolling
Updated:  5/17/2011
Mercy St John's Medical Center
mi
from
St Louis, MO
Normothermia Protocol for Traumatic Brain Injury Patients
Normothermia Protocol for Traumatic Brain Injury Patients: An Outcome Study
Status: Enrolling
Updated: 5/17/2011
Mercy St John's Medical Center
mi
from
St Louis, MO
Click here to add this to my saved trials
Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).
Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).
Status: Enrolling
Updated:  5/24/2011
MDA/ALS Center of Hope
mi
from
Philadelphia, PA
Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).
Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).
Status: Enrolling
Updated: 5/24/2011
MDA/ALS Center of Hope
mi
from
Philadelphia, PA
Click here to add this to my saved trials